Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Stein, Alexander; Moehler, Markus; Trojan, Joerg et al.
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonistsCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. Bd. 130. 2018 S. 13-26
Almstedt, K; Schmidt, M
Immunonkologie beim Mammakarzinom - von der Diagnose bis zur Therapiegyne. Bd. 39. 2018 S. 20-24
Moehler, Markus
Immunotherapy in Gastrointestinal Carcinoma - How to Separate Hope from HypeONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 264-265
Alsina, Maria; Moehler, Markus; Lorenzen, Sylvie
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative StrategiesONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 266-271
Derks, M. G. M.; Bastiaannet, E.; van de Water, W. et al.
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trialEUROPEAN JOURNAL OF CANCER. Bd. 99. 2018 S. 1-8
Cook, Nigel; Balp, Maria-Magdalena; Weiss, Olivia et al.
Impact of Non-Alcoholic Steatohepatitis (NASH) on Patients' Quality of Life: Results from a Patient Preference StudyHEPATOLOGY. Bd. 68. 2018 S. 1001A-1002A
Abd Kadir, Sharifah Shahnaz Syed; Christopeit, Maximilian; Wulf, Gerald et al.
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosisEUROPEAN JOURNAL OF HAEMATOLOGY. Bd. 101. H. 3. 2018 S. 305-317
Breuksch, Ines; Welter, Jonas; Bauer, Heide-Katharina et al.
In renal cell carcinoma the PTEN splice variant PTEN-Delta shows similar function as the tumor suppressor PTEN itselfCELL COMMUNICATION AND SIGNALING. Bd. 16. 2018
Mittler, J.; Heinrich, S.; Lang, H.
Indications for transplantation and bridging procedures for primary hepatobiliary malignanciesCHIRURG. Bd. 89. H. 11. 2018 S. 865-871
Pleimes, Dirk; Moebus, Volker; Mayer, Frank et al.
Induced Myerosuppression and Recommendation for Monitoring of Absolute Neutrophil Counts in Patients Treated with Epirubicin and Cyclophosphamide in Early Breast Cancer: Results from a Phase 2a Collaborative Trial of the AGO-B and CESAR Study GroupsBLOOD. Bd. 132. 2018